Horsens Regional Hospital
Horsens, 8700, Denmark
NCT Number: NCT04796701
The objective of this study is to evaluate the effect of a transitional care intervention on readmissions among older medical patients.
The proportion of older people is rapidly growing. These changes represent a challenge for healthcare systems. 20% of all hospital admitted patients ≥ 65 years are readmitted within the first 30 days after discharge. Prior transitional care research has mainly focused on either hospital-based or community-based interventions with no or little intervention elements in both settings. The results show different effects on readmission rates. This calls for new research on trans-sectorial interventions with both pre- and post-discharge elements.
Looking for future studies?
Notify Me75 year and older
All sexes
Interventional
Not applicable
Horsens, 8700, Denmark
Design:
Non-randomized controlled trial.
Participants For eligibility criteria - see elsewhere. Intervention group • Patients living in Odder, Skanderborg or Hedensted municipality
Control group
Follow-Home Intervention
The intervention group receives following intervention:
If possible, all included participants are physically followed home by a hospital-based project worker on the day of discharge. During the visit, the focus is on: basic human needs, medication review reconciliation, and a comprehensive geriatric assessment. Problems, challenges and concerns are discussed. Finally, a conference for the following working day is arranged either as a physical visit or a video conference. The patient, relatives, community-based nurse and project worker are invited to participate and health status and challenges are discussed They are recommended to contact the project worker about health and practical issues up to 7 days after discharge where the intervention ends. Subsequently, the responsibility for treatment and care is assigned to the GP and home healthcare provider.
Usual care
Patients in the control group recieves the following usual discharge procedure:
On the day of discharge, the hospital-based nurse digitally sends a summery of the hospital stay and a treatment and care plan to the community-based nurse. If needed, the hospital-based nurse contacts the community-based nurse by phone as a supplement to the plan. Finally, a discharge letter conducted by the hospital-based doctor is digitally sent to the GP.
Method:
Inclusion of participants is consecutive. Inclusion period was between 01/02/17 to 31/12/19. In total, approximately 1200 patients were included .
Data collection Outcome data will be retrieved from CROSS-TRACKS database at 30 days after discharge from index admission.
Analysis
Intervention and Control group will be matched on 3 variables on individual level:
All readmissions are included in the analysis (not only first time readmissions). That means that one patient can be included several times.
Logistic regression adjusted for possible confounders will be used when analysing the outcomes. Confounders are chosen through a study specific DAG.
Sub-group analysis will be conducted according to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
x
Time frame: Readmission will be assessed at 30 days after hospital discharge in both intervention and control group
Unplanned all-cause readmission
Time frame: Mortality will be assessed at 30 days after hospital discharge in both intervention and control group
All-cause mortality
University of Aarhus
Other
Effect of a Transitional Care Intervention From Hospital to Home on Readmissions Among Older Medical Patients: a Quasi-experimental Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsNCT05629728
Frailty, Pathologic Processes
Daejeon, South Korea
View Trial DetailsNCT06576297
Aging, Frailty
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05199857
Fontan Physiology, Frailty
Ann Arbor, Michigan, United States
View Trial Details